Compare ADMA Biologics Inc (ADMA) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Alliant Energy Corporation — how do they compare? ADMA Biologics Inc trades at $9.26 (market cap $2.13B), while Alliant Energy Corporation trades at $76.42 (market cap $20.06B). The key difference: Alliant Energy Corporation is far larger — about 9.4× ADMA Biologics Inc's market cap, and Alliant Energy Corporation pays a 2.69% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | LNT | |
|---|---|---|
Market Cap | $2.13B | $20.06B |
Sector | Health | Utilities |
52-Week High | $20.38 | $78.03 |
52-Week Low | $7.60 | $61.26 |
Enterprise Value | $2.20B | $31.78B |
Dividend Yield | — | 2.69% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
LNT trades at $77.65, down 0.49% on the day, with a bullish technical signal from moving averages and key resistance at $78. The company reported revenue of $4.36B in 2025 with net income of $810M, and recent quarters show mixed earnings performance against estimates. A $13.4B investment plan supports growth in data center demand and clean energy expansion, while analyst consensus is a Buy with a $75.67 price target.
LNT offers steady utility earnings growth and a dividend yield, but faces risks from rising debt levels and interest expenses. The stock's valuation multiples are above sector averages, requiring continued execution on capital investments to justify premium pricing amid competitive and regulatory pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
